Wednesday, February 10, 2010, 1:11PM AEST - The Australian Stockmarket closes in 2 hours and 54 minutes.
To create a watchlist or portfolio of shares, Register

BioMimetic Therapeutics Inc. (BMTI)

8:00AM AEST: 11.86 USD  Up 0.32 (2.77%)  
 MORE ON BMTI 
Quotes
HereSummary
Charts
Technical Analysis
News & Info
Company
Analyst Coverage
Ownership
Financials
 BioMimetic Therapeutics, Inc. (NGM:BMTI) Delayed quote dataEdit
Last Trade:11.86 USD
Trade Time: 8:00AM AEST
Change:Up 0.32 (2.77%)
Prev Close:11.54
Open:11.72
Bid:11.04 x 100
Ask:12.52 x 100
1y Target Est:21.60
Day's Range:11.68 - 12.12
52wk Range:6.52 - 15.81
Volume:40,482
Avg Vol (3m):88,976.2
Market Cap:258.44M
P/E (ttm):N/A
EPS (ttm):-1.75
Div & Yield:N/A (N/A%)
[Chart]
1d  5d  3m  6m  1y  2y  5y 
 Add BMTI to Portfolio   Download Data

 HEADLINES 
How the Brokers Stack Up
at Barrons.com (Sat, Feb 6)
BIOMIMETIC THERAPEUTICS, INC. Files SEC form 8-K, Other Events, Financial Statements and Exhibits
EDGAR Online (Thu, Feb 4)
BioMimetic Therapeutics, Inc. Patent Portfolio Further Strengthened
Business Wire (Tue, Feb 2)
BIOMIMETIC THERAPEUTICS, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Other Events, Financial
EDGAR Online (Fri, Jan 8)
BioMimetic Therapeutics Strengthens its Agreement with Novartis for Exclusive Supply of rhPDGF-BB
Business Wire (Thu, Jan 7)
BIOMIMETIC THERAPEUTICS, INC. Files SEC form 8-K, Other Events
EDGAR Online (Thu, Dec 24)
[$$] 13D Filings
at Barrons.com (Sat, Dec 12)
BioMimetic Therapeutics Ships Augment Bone Graft to Canadian Distributor
Business Wire (Sat, Dec 12)
BIOMIMETIC THERAPEUTICS, INC. Files SEC form 8-K, Other Events, Financial Statements and Exhibits
EDGAR Online (Thu, Dec 10)
Novo A/S Implements 10b5-1 Trading Plan for Purchase of Additional BioMimetic Therapeutics Shares
Business Wire (Wed, Dec 9)
More Headlines for BMTI...

 ANALYST 
EPS Est (next year) (Dec-09) :-1.55
EPS Est (in 2 years) (Dec-10) :-1.63
Avg Rec (current)*:1.4
PEG Ratio:N/A
* (Strong Buy) 1.0 - 5.0 (Strong Sell)
Analyst Opinion - Estimates

 BUSINESS SUMMARY 
BioMimetic Therapeutics, Inc. develops and commercializes regenerative protein therapeutic-device combination products. Its products are primarily used for bone and tissue regeneration for the repair and healing of musculoskeletal injuries and con...

Full Company Profile



Add to My Portfolio Add to Portfolio    Email to a Friend Email to a Friend
Get Summary for Another Symbol:
Symbol Lookup
Latest News7 Indices